Operating Metrics 營運指標
GSK plc (GSK) Operating Metrics 營運指標
GSK plc GSK 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-06-30
最新營運指標
季度趨勢
| 指標 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 | Q3 FY2024 |
|---|---|---|---|---|---|---|---|---|
| Specialty Medicines Sales | £3,782M | £3,226M | £3,805M | £3,409M | £3,327M | £2,933M | £3,298M | £2,966M |
| Vaccines Sales | £2,284M | £2,149M | £2,293M | £2,678M | £2,091M | £2,095M | £2,212M | £2,650M |
| General Medicines Sales | £2,343M | £2,254M | £2,520M | £2,460M | £2,568M | £2,488M | £2,607M | £2,396M |
| HIV Sales | £2,078M | £1,824M | £2,149M | £1,944M | £1,880M | £1,714M | £1,969M | £1,750M |
| Shingrix Sales | £888M | £1,026M | £1,008M | £830M | £853M | £867M | £848M | £739M |
| Arexvy Sales | £192M | £65M | £198M | £251M | £66M | £78M | £158M | £188M |
| Trelegy Sales | £775M | £646M | £740M | £736M | £835M | £675M | £669M | £600M |
| Oncology Sales | £569M | £512M | £567M | £511M | £484M | £415M | £408M | £373M |
資料來源
- GSK Second Quarter 2026 Results Announcement · GSK plc · 2026-07-28
- GSK First Quarter 2026 Results Announcement · GSK plc · 2026-04-29
- GSK Full-Year and Fourth Quarter 2025 Results Announcement · GSK plc · 2026-02-04
- GSK Third Quarter 2025 Results Announcement · GSK plc · 2025-10-29
- GSK Second Quarter 2025 Results Announcement · GSK plc · 2025-07-30
- GSK First Quarter 2025 Results Announcement · GSK plc · 2025-04-30
- GSK Full-Year and Fourth Quarter 2024 Results Announcement · GSK plc · 2025-02-05
- GSK Third Quarter 2024 Results Announcement · GSK plc · 2024-10-30